2024-04-26 23:38:34, GGRNA : RefSeq release 60 (20130726)
LOCUS NM_005920 5996 bp mRNA linear PRI 17-APR-2013 DEFINITION Homo sapiens myocyte enhancer factor 2D (MEF2D), transcript variant 1, mRNA. ACCESSION NM_005920 VERSION NM_005920.3 GI:410442513 KEYWORDS RefSeq. SOURCE Homo sapiens (human) ORGANISM Homo sapiens Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae; Homo. REFERENCE 1 (bases 1 to 5996) AUTHORS She,H., Yang,Q., Shepherd,K., Smith,Y., Miller,G., Testa,C. and Mao,Z. TITLE Direct regulation of complex I by mitochondrial MEF2D is disrupted in a mouse model of Parkinson disease and in human patients JOURNAL J. Clin. Invest. 121 (3), 930-940 (2011) PUBMED 21393861 REMARK GeneRIF: direct regulation of complex I by mitochondrial MEF2D underlies its neuroprotective effects, and dysregulation of this pathway may contribute to Parkinson disease REFERENCE 2 (bases 1 to 5996) AUTHORS Aude-Garcia,C., Collin-Faure,V., Bausinger,H., Hanau,D., Rabilloud,T. and Lemercier,C. TITLE Dual roles for MEF2A and MEF2D during human macrophage terminal differentiation and c-Jun expression JOURNAL Biochem. J. 430 (2), 237-244 (2010) PUBMED 20590529 REMARK GeneRIF: MEF2A and MEF2D play dual roles in human macrophages differentiation, as activators and as repressors of c-jun transcription. REFERENCE 3 (bases 1 to 5996) AUTHORS Czubryt,M.P., Lamoureux,L., Ramjiawan,A., Abrenica,B., Jangamreddy,J. and Swan,K. TITLE Regulation of cardiomyocyte Glut4 expression by ZAC1 JOURNAL J. Biol. Chem. 285 (22), 16942-16950 (2010) PUBMED 20363751 REMARK GeneRIF: ZAC1 is a novel and previously unknown regulator of cardiomyocyte Glut4 expression and glucose uptake; MEF2 is a regulator of ZAC1 expression in response to induction of hypertrophy REFERENCE 4 (bases 1 to 5996) AUTHORS Yang,Q., She,H., Gearing,M., Colla,E., Lee,M., Shacka,J.J. and Mao,Z. TITLE Regulation of neuronal survival factor MEF2D by chaperone-mediated autophagy JOURNAL Science 323 (5910), 124-127 (2009) PUBMED 19119233 REMARK GeneRIF: MEF2D levels were increased in the brains patients with Parkinson's disease REFERENCE 5 (bases 1 to 5996) AUTHORS Liu,G., Han,J., Profirovic,J., Strekalova,E. and Voyno-Yasenetskaya,T.A. TITLE Galpha13 regulates MEF2-dependent gene transcription in endothelial cells: role in angiogenesis JOURNAL Angiogenesis 12 (1), 1-15 (2009) PUBMED 19093215 REMARK GeneRIF: MEF2 proteins are an important component in Galpha13-mediated angiogenesis. REFERENCE 6 (bases 1 to 5996) AUTHORS Zhao,M., New,L., Kravchenko,V.V., Kato,Y., Gram,H., di Padova,F., Olson,E.N., Ulevitch,R.J. and Han,J. TITLE Regulation of the MEF2 family of transcription factors by p38 JOURNAL Mol. Cell. Biol. 19 (1), 21-30 (1999) PUBMED 9858528 REFERENCE 7 (bases 1 to 5996) AUTHORS Yang,C.C., Ornatsky,O.I., McDermott,J.C., Cruz,T.F. and Prody,C.A. TITLE Interaction of myocyte enhancer factor 2 (MEF2) with a mitogen-activated protein kinase, ERK5/BMK1 JOURNAL Nucleic Acids Res. 26 (20), 4771-4777 (1998) PUBMED 9753748 REFERENCE 8 (bases 1 to 5996) AUTHORS Ornatsky,O.I. and McDermott,J.C. TITLE MEF2 protein expression, DNA binding specificity and complex composition, and transcriptional activity in muscle and non-muscle cells JOURNAL J. Biol. Chem. 271 (40), 24927-24933 (1996) PUBMED 8798771 REFERENCE 9 (bases 1 to 5996) AUTHORS Hobson,G.M., Krahe,R., Garcia,E., Siciliano,M.J. and Funanage,V.L. TITLE Regional chromosomal assignments for four members of the MADS domain transcription enhancer factor 2 (MEF2) gene family to human chromosomes 15q26, 19p12, 5q14, and 1q12-q23 JOURNAL Genomics 29 (3), 704-711 (1995) PUBMED 8575763 REFERENCE 10 (bases 1 to 5996) AUTHORS Breitbart,R.E., Liang,C.S., Smoot,L.B., Laheru,D.A., Mahdavi,V. and Nadal-Ginard,B. TITLE A fourth human MEF2 transcription factor, hMEF2D, is an early marker of the myogenic lineage JOURNAL Development 118 (4), 1095-1106 (1993) PUBMED 8269842 COMMENT REVIEWED REFSEQ: This record has been curated by NCBI staff. The reference sequence was derived from AL365181.24, DC377787.1, BC054520.1, AL139412.10 and R42560.1. On Nov 1, 2012 this sequence version replaced gi:40254821. Summary: This gene is a member of the myocyte-specific enhancer factor 2 (MEF2) family of transcription factors. Members of this family are involved in control of muscle and neuronal cell differentiation and development, and are regulated by class II histone deacetylases. Fusions of the encoded protein with Deleted in Azoospermia-Associated Protein 1 (DAZAP1) due to a translocation have been found in an acute lymphoblastic leukemia cell line, suggesting a role in leukemogenesis. The encoded protein may also be involved in Parkinson disease and myotonic dystrophy. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Oct 2012]. Transcript Variant: This variant (1) represents the longer transcript and encodes the longer isoform (1, also known as hMEF2Dab). Sequence Note: This RefSeq record was created from transcript and genomic sequence data to make the sequence consistent with the reference genome assembly. The genomic coordinates used for the transcript record were based on transcript alignments. Publication Note: This RefSeq record includes a subset of the publications that are available for this gene. Please see the Gene record to access additional publications. ##Evidence-Data-START## Transcript exon combination :: BC054520.1, L16794.1 [ECO:0000332] RNAseq introns :: mixed/partial sample support ERS025081, ERS025082 [ECO:0000350] ##Evidence-Data-END## COMPLETENESS: complete on the 3' end. PRIMARY REFSEQ_SPAN PRIMARY_IDENTIFIER PRIMARY_SPAN COMP 1-6 AL365181.24 11974-11979 c 7-105 DC377787.1 7-105 106-776 BC054520.1 1-671 777-777 AL139412.10 41505-41505 c 778-1250 BC054520.1 673-1145 1251-1251 AL139412.10 37668-37668 c 1252-3840 BC054520.1 1147-3735 3841-5792 AL139412.10 24471-26422 c 5793-5996 R42560.1 1-204 c FEATURES Location/Qualifiers source 1..5996 /organism="Homo sapiens" /mol_type="mRNA" /db_xref="taxon:9606" /chromosome="1" /map="1q12-q23" gene 1..5996 /gene="MEF2D" /note="myocyte enhancer factor 2D" /db_xref="GeneID:4209" /db_xref="HGNC:6997" /db_xref="HPRD:02810" /db_xref="MIM:600663" exon 1..357 /gene="MEF2D" /inference="alignment:Splign:1.39.8" variation 115 /gene="MEF2D" /replace="a" /replace="c" /db_xref="dbSNP:201342279" exon 358..549 /gene="MEF2D" /inference="alignment:Splign:1.39.8" STS 423..598 /gene="MEF2D" /standard_name="MARC_16813-16814:1033503049:1" /db_xref="UniSTS:268128" misc_feature 478..480 /gene="MEF2D" /note="upstream in-frame stop codon" variation 484 /gene="MEF2D" /replace="a" /replace="c" /db_xref="dbSNP:28730744" CDS 496..2061 /gene="MEF2D" /note="isoform 1 is encoded by transcript variant 1; MADS box transcription enhancer factor 2, polypeptide D; myocyte-specific enhancer factor 2D" /codon_start=1 /product="myocyte-specific enhancer factor 2D isoform 1" /protein_id="NP_005911.1" /db_xref="GI:5174545" /db_xref="CCDS:CCDS1143.1" /db_xref="GeneID:4209" /db_xref="HGNC:6997" /db_xref="HPRD:02810" /db_xref="MIM:600663" /translation="
MGRKKIQIQRITDERNRQVTFTKRKFGLMKKAYELSVLCDCEIALIIFNHSNKLFQYASTDMDKVLLKYTEYNEPHESRTNADIIETLRKKGFNGCDSPEPDGEDSLEQSPLLEDKYRRASEELDGLFRRYGSTVPAPNFAMPVTVPVSNQSSLQFSNPSGSLVTPSLVTSSLTDPRLLSPQQPALQRNSVSPGLPQRPASAGAMLGGDLNSANGACPSPVGNGYVSARASPGLLPVANGNSLNKVIPAKSPPPPTHSTQLGAPSRKPDLRVITSQAGKGLMHHLTEDHLDLNNAQRLGVSQSTHSLTTPVVSVATPSLLSQGLPFSSMPTAYNTDYQLTSAELSSLPAFSSPGGLSLGNVTAWQQPQQPQQPQQPQPPQQQPPQPQQPQPQQPQQPQQPPQQQSHLVPVSLSNLIPGSPLPHVGAALTVTTHPHISIKSEPVSPSRERSPAPPPPAVFPAARPEPGDGLSSPAGGSYETGDRDDGRGDFGPTLGLLRPAPEPEAEGSAVKRMRLDTWTLK
" misc_feature 499..729 /gene="MEF2D" /note="MEF2 (myocyte enhancer factor 2)-like/Type II subfamily of MADS ( MCM1, Agamous, Deficiens, and SRF (serum response factor) box family of eukaryotic transcriptional regulators. Binds DNA and exists as hetero and homo-dimers. Differs from SRF-like/Type I...; Region: MADS_MEF2_like; cd00265" /db_xref="CDD:29020" misc_feature order(499..507,511..513,517..519,532..534,538..540, 550..555,562..567,571..576,583..588,592..597,607..609) /gene="MEF2D" /note="DNA binding site [nucleotide binding]" /db_xref="CDD:29020" misc_feature order(556..558,577..582,589..594,598..603,610..612, 625..627,631..633,637..639,655..657,661..663,679..681, 688..693,700..702,709..714) /gene="MEF2D" /note="dimerization interface [polypeptide binding]; other site" /db_xref="CDD:29020" misc_feature 670..672 /gene="MEF2D" /note="putative phosphorylation site [posttranslational modification]; other site" /db_xref="CDD:29020" misc_feature 778..960 /gene="MEF2D" /note="Holliday junction regulator protein family C-terminal repeat; Region: HJURP_C; pfam12347" /db_xref="CDD:152782" misc_feature 787..789 /gene="MEF2D" /experiment="experimental evidence, no additional details recorded" /note="phosphorylation site" misc_feature 811..813 /gene="MEF2D" /experiment="experimental evidence, no additional details recorded" /note="phosphorylation site" misc_feature 823..825 /gene="MEF2D" /experiment="experimental evidence, no additional details recorded" /note="phosphorylation site" misc_feature 856..858 /gene="MEF2D" /experiment="experimental evidence, no additional details recorded" /note="Phosphoserine, by PKA; propagated from UniProtKB/Swiss-Prot (Q14814.1); phosphorylation site" misc_feature 1033..1035 /gene="MEF2D" /experiment="experimental evidence, no additional details recorded" /note="Phosphoserine, by MAPK7; propagated from UniProtKB/Swiss-Prot (Q14814.1); phosphorylation site" misc_feature 1033..1035 /gene="MEF2D" /experiment="experimental evidence, no additional details recorded" /note="phosphorylation site" /db_xref="HPRD:03952" misc_feature 1129..1131 /gene="MEF2D" /experiment="experimental evidence, no additional details recorded" /note="phosphorylation site" misc_feature 1186..1188 /gene="MEF2D" /experiment="experimental evidence, no additional details recorded" /note="Phosphoserine; propagated from UniProtKB/Swiss-Prot (Q14814.1); phosphorylation site" misc_feature 1228..1230 /gene="MEF2D" /experiment="experimental evidence, no additional details recorded" /note="N6-acetyllysine; propagated from UniProtKB/Swiss-Prot (Q14814.1); acetylation site" misc_feature 1246..1248 /gene="MEF2D" /experiment="experimental evidence, no additional details recorded" /note="Phosphoserine; propagated from UniProtKB/Swiss-Prot (Q14814.1); phosphorylation site" misc_feature 1351..1371 /gene="MEF2D" /experiment="experimental evidence, no additional details recorded" /note="propagated from UniProtKB/Swiss-Prot (Q14814.1); Region: Beta domain" misc_feature 1357..1362 /gene="MEF2D" /inference="non-experimental evidence, no additional details recorded" /note="Cleavage (Probable); propagated from UniProtKB/Swiss-Prot (Q14814.1); cleavage site" misc_feature 1357..1359 /gene="MEF2D" /experiment="experimental evidence, no additional details recorded" /note="proteolytic cleavage site; modified site" /db_xref="HPRD:03457" misc_feature 1810..1812 /gene="MEF2D" /experiment="experimental evidence, no additional details recorded" /note="N6-acetyllysine, alternate; propagated from UniProtKB/Swiss-Prot (Q14814.1); acetylation site" misc_feature 1825..1827 /gene="MEF2D" /experiment="experimental evidence, no additional details recorded" /note="Phosphoserine; propagated from UniProtKB/Swiss-Prot (Q14814.1); phosphorylation site" STS 496..1014 /gene="MEF2D" /standard_name="Mef2d" /db_xref="UniSTS:265605" exon 550..753 /gene="MEF2D" /inference="alignment:Splign:1.39.8" STS 651..1014 /gene="MEF2D" /standard_name="Mef2d" /db_xref="UniSTS:238138" exon 754..891 /gene="MEF2D" /inference="alignment:Splign:1.39.8" exon 892..1102 /gene="MEF2D" /inference="alignment:Splign:1.39.8" exon 1103..1159 /gene="MEF2D" /inference="alignment:Splign:1.39.8" exon 1160..1350 /gene="MEF2D" /inference="alignment:Splign:1.39.8" STS 1216..1326 /gene="MEF2D" /standard_name="D1S262E" /db_xref="UniSTS:147387" exon 1351..1371 /gene="MEF2D" /inference="alignment:Splign:1.39.8" exon 1372..1501 /gene="MEF2D" /inference="alignment:Splign:1.39.8" exon 1502..1742 /gene="MEF2D" /inference="alignment:Splign:1.39.8" exon 1743..2049 /gene="MEF2D" /inference="alignment:Splign:1.39.8" exon 2050..5985 /gene="MEF2D" /inference="alignment:Splign:1.39.8" STS 2597..3478 /gene="MEF2D" /standard_name="MEF2D_2065" /db_xref="UniSTS:280845" STS 3154..3311 /gene="MEF2D" /standard_name="RH70462" /db_xref="UniSTS:33507" STS 3268..3480 /gene="MEF2D" /standard_name="RH81006" /db_xref="UniSTS:89519" polyA_site 3489 /gene="MEF2D" STS 4650..4725 /gene="MEF2D" /standard_name="1996" /db_xref="UniSTS:56140" STS 5761..5976 /gene="MEF2D" /standard_name="HSC1IB102" /db_xref="UniSTS:25334" polyA_signal 5949..5954 /gene="MEF2D" polyA_site 5985 /gene="MEF2D" ORIGIN
ctttccccccacccctcaagctaggctgagctgtgcctacgtcggcctcgactcccgggggctggaggagttacctttggagcccgaaaggaggaaggaagcaaaatatcaacaacagccgaggcggctcaggcgctcggccccggttccccgcttgcctgccgcccgcctgctggcccccgcgcccacgacgggggcccaggcctcacggcgccgcccagggcccgcgcggacgccggcctcatttattattctccccgcccggagctgcggcttcccggtgttgaagatcccccggaccaggggcgagggctacccgctctttgccgtgacaacaccgttcccccagccgggctggaggctgtgcagaaggtatcctgcagaccatgaactgagcactgttcccagaccgttcatgagcacagtgtaaggtgtgccgagacccaccacccagcgagcccctcccctccgtagcactgaggacccccggagaagatggggaggaaaaagattcagatccagcgaatcaccgacgagcggaaccgacaggtgactttcaccaagcggaagtttggcctgatgaagaaggcgtatgagctgagcgtgctatgtgactgcgagatcgcactcatcatcttcaaccactccaacaagctgttccagtacgccagcaccgacatggacaaggtgctgctcaagtacacggagtacaatgagccacacgagagccgcaccaacgccgacatcatcgagaccctgaggaagaagggcttcaacggctgcgacagccccgagcccgacggggaggactcgctggaacagagccccctgctggaggacaagtaccgacgcgccagcgaggagctcgacgggctcttccggcgctatgggtcaactgtcccggcccccaactttgccatgcctgtcacggtgcccgtgtccaatcagagctcactgcagttcagcaatcccagcggctccctggtcaccccttccctggtgacatcatccctcacggacccgcggctcctgtccccccagcagccagcactacagaggaacagtgtgtctcctggcctgccccagcggccagctagtgcgggggccatgctggggggtgacctgaacagtgctaacggagcctgccccagccctgttgggaatggctacgtcagtgctcgggcttcccctggcctcctccctgtggccaatggcaacagcctaaacaaggtcatccctgccaagtctccacccccacctacccacagcacccagcttggagcccccagccgcaagcccgacctgcgagtcatcacttcccaggcaggaaaggggttaatgcatcacttgactgaggaccatttagatctgaacaatgcccagcgccttggggtctcccagtctactcattcgctcaccaccccagtggtttctgtggcaacgccgagtttactcagccagggcctccccttctcttccatgcccactgcctacaacacagattaccagttgaccagtgcagagctctcctccttaccagcctttagttcacctggggggctgtcgctaggcaatgtcactgcctggcaacagccacagcagccccagcagccgcagcagccacagcctccacagcagcagccaccgcagccacagcagccacagccacagcagcctcagcagccgcaacagccacctcagcaacagtcccacctggtccctgtatctctcagcaacctcatcccgggcagccccctgccccacgtgggtgctgccctcacagtcaccacccacccccacatcagcatcaagtcagaaccggtgtccccaagccgtgagcgcagccctgcgcctccccctccagctgtgttcccagctgcccgccctgagcctggcgatggtctcagcagcccagccgggggatcctatgagacgggagaccgggatgacggacggggggacttcgggcccacactgggcctgctgcgcccagccccagagcctgaggctgagggctcagctgtgaagaggatgcggcttgatacctggacattaaagtgacgattcccactcccctcctctcagcctccctgatgaagagttgacaatctcaccgcccgcccttccctgccccgggctcctcccgctcgacccccacttcctttcttgtgcttcgtgtcctgttgacggttacatttgtgtataattattatattattattattattattatattttttttaatttggattctcgctttggagagggggatgctctcatcccctctttctgtaccccccaccattttcactggctggggggctctctttttcgcgggaaggggggacactttgcacgttgtacacatatgctgcaggaagggggtggggggcccaataaggcctttgggaaaggacaggtgccgagccctgcatgtggagccctcccaccccacccccagatagagggaaataaccaaaaaactaccaaacaacagaaacccacactctagactgaaaccccaaagtgggcttgatgggtgggtttgtgtttcaaggggaaagtgaggcagaggttctgaaaagggtctctgtttttgtgttcatgtagccataggcacatggagcagaatacttaagcctggcccccaaatgcccctgcacacacacgtgccacacctgcgctgattcttgtgtgtgctgcacccccaaggtgtgtgggtgctggctgagctttgggccgggaaggcagcctgggaatctgaggctggagacaggggtttgaggtgggggcctctctggaagcacatttggagggaaagacaagagagccatgaggagagggctgaggagggcagaagggctaggcagggggcaaattgagcccctcccttccccagtttttctctaagatatacagtgcaatagctccccacccctcagttgacgccagccctgtaaagctggccacagtgtgcagggagaatggggagagggtcttcagtgaggtggctggggcgagagtcggcctggacttccctggggtgctccaggccagagctctttcattggggcgagtgtggtgaggggacgtccttggtcttgcacgcacactacctgggggagtcaacactgggatggtctgtggggtgggagggcctacggatgggtccgtagaggtcccacctccctcattcctccttggcccctctccctagcttctcctgttagctccttctgctcctgaccccacctccttgctcttggcgcccctattgtctctggctacctccttgtcccaccacctccaggctgcatcccaccttccctcttggctactgtaattgtaaatagcgacctttggaaaacgttagcggtgtaacagtccaggaaactgtttttttttgttgttgttgtattgatatgaaatgagattctatttttgtcaaagtatattgtaataataatgactcaaacggcccgtactgtacagacgagattcttctgctgttgttcttgctcccctcccctcctctgagtccgcccctccctgctgcctcctcagtggggcagtgggcaaggggcccaggggcagccgaagcacggggtcctgagacctcaggcaggattggagatcaaaccagagggggcaggcccccagcctgctctctaggatcaccccccgccctaaggggcctggcctggggtgacgtggccaggcagactgtctgccccactccttcacacaagcccagctcctctgcccaaggggtgcggcgcccccttggggtttcctcccagttggagagtagagttaagacaaggcccagttttgtgttagccgaccgtctttgcccacctctatgacccagcctcttgcagtattcccatacttgatgcagggaaggaaccagaagcagaggggcctctacgcaggtacacacgtgtacctgagtgtgttcatgagggcatctggtgtttatgtgtctgagtgtagctttgtatttatgtgtgtgtgtgtgtgtatgtctgattgcacgggtgtacttttgtatttatgtgtgtgtgtggttgcacgggtgtgcctctgtgtgtctctgaccctggctgggtgtgtgtgcaaatctgtgtgactggagctctaggggcatctctgtgtctgagtgtgcctggtgtgtgtttacaaagggagagttggctgctccagctccacagccctgggaccccaactcctgtcttccctgctcctttccctgtgttcaccctcagctctgacacattgaactgcagttggggggattggcagttagccctctgtgcttctccctgcagccctacctctgccaaggtctctccctccagggacctctgcttccacccacatatgtccacttagtcacccacacttgacacagttcctggagtaccctcttcccccaaccccagacctgctttcagagcaaaactcaagtccctcttcctccgtgaagcttctccctcagctgagcagtgatcacttactcactcttaaccccaatccgctgactgggtggggacagcacgtccagccttcccacctctcctgcaggcttctagacggagtttcaaaaactgatgagcctcgatccagggcttgaaagaagccagggtgtaatcttgttcatgcatgcgtccccagagcctcgcccagtgcctggcacatagtaggcactcaataaatgctgaatgggtgaatagttgaatgataggtgctcaataaatgaatgaatggccttcccttctcaggctattcccaccattagtctgcccacctttctaggctgggcttggccaccattaaacacggggtgggggtgagggcccctgcaattcacggtgcaatattcaccagttttgccctctgcctcataaaggcaaacctggcttttgattaccatgtgtggatgtttcagtgtcctttcttctctgtccctggggatggggtggtctgtgaatatgtgacatttctgcagttcagtatccgaaggtttctcttgggggtaggggctcctgggcggccagatgaatgggtccctgggaacccagacctcagatgaggacttaatgtcttcttcctctcaagccaaattcgcctccacccactccctctgaagaactgggcatttgccaaagtaaccactggagtcatctaatggccctccccctccccaggtttcccacagctttcagggacagtgggcaagaggacacccccccccaccacctcagtggaacacaccattctccccccctcaacagcacactcagtgcagcaagactgacccctgaccccctcccagccctccctaccttggacaggaaggaagtaatgcaccttctcttgctgattatttatttgtttggagagacagaaatgtaaaagtgtatctagaaatatctatatctctatatatttttaactgactctttggaatcccctggggtggggtgaggggtaagtttaggctttcgcggaggggaggagacatggagcctgggaactccttgttctcccctctgctgcctctccccaccccttaaagcagttggtagaaggaatggtatttgtatggggggagggaggctggaatggagaatctggattctctcctcttccccattctccagagggagggaggtggtgaggaagaggaagggaggggcaggatgggccatggaggtgccccacccccacacctgacaatcacccacactcctggggctcttcctgggtcctggggcagggcgagtccaagtgtgaggctgttgatttgttttcaatatttcttttcgtgctgtatggtgatgctttcttagtattctacacaataagaaaagacaaagtcctcgagattcttatgagttttgtttgaaaactctttcactatatttgttgtaaagaggtttactattaaaagaaaaagaatacacgtttctgatacttcggaaaaaaaaaaa
//
ANNOTATIONS from NCBI Entrez Gene (20130726): GeneID:4209 -> Molecular function: GO:0000977 [RNA polymerase II regulatory region sequence-specific DNA binding] evidence: IDA GeneID:4209 -> Molecular function: GO:0000981 [sequence-specific DNA binding RNA polymerase II transcription factor activity] evidence: IDA GeneID:4209 -> Molecular function: GO:0003700 [sequence-specific DNA binding transcription factor activity] evidence: NAS GeneID:4209 -> Molecular function: GO:0005515 [protein binding] evidence: IPI GeneID:4209 -> Molecular function: GO:0033613 [activating transcription factor binding] evidence: IPI GeneID:4209 -> Molecular function: GO:0042826 [histone deacetylase binding] evidence: IPI GeneID:4209 -> Molecular function: GO:0046983 [protein dimerization activity] evidence: IEA GeneID:4209 -> Biological process: GO:0001649 [osteoblast differentiation] evidence: IEA GeneID:4209 -> Biological process: GO:0001958 [endochondral ossification] evidence: IEA GeneID:4209 -> Biological process: GO:0002062 [chondrocyte differentiation] evidence: IEA GeneID:4209 -> Biological process: GO:0006366 [transcription from RNA polymerase II promoter] evidence: IDA GeneID:4209 -> Biological process: GO:0006915 [apoptotic process] evidence: IEA GeneID:4209 -> Biological process: GO:0007399 [nervous system development] evidence: IEA GeneID:4209 -> Biological process: GO:0007512 [adult heart development] evidence: IEP GeneID:4209 -> Biological process: GO:0007517 [muscle organ development] evidence: TAS GeneID:4209 -> Biological process: GO:0035914 [skeletal muscle cell differentiation] evidence: IEA GeneID:4209 -> Biological process: GO:0045944 [positive regulation of transcription from RNA polymerase II promoter] evidence: IDA GeneID:4209 -> Cellular component: GO:0005634 [nucleus] evidence: IDA GeneID:4209 -> Cellular component: GO:0005730 [nucleolus] evidence: IDA GeneID:4209 -> Cellular component: GO:0043231 [intracellular membrane-bounded organelle] evidence: IDA
by
@meso_cacase at
DBCLS
This page is licensed under a Creative Commons Attribution 2.1 Japan License.